Endava (NYSE:DAVA - Get Free Report) is scheduled to post its quarterly earnings results before the market opens on Tuesday, November 12th. Analysts expect Endava to post earnings of $0.29 per share for the quarter. Endava has set its Q1 2025 guidance at 0.260-0.280 EPS and its FY 2025 guidance at 1.410-1.480 EPS.Individual interested in participating in the company's earnings conference call can do so using this link.
Endava (NYSE:DAVA - Get Free Report) last announced its earnings results on Thursday, September 19th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of $0.09 by ($0.13). The company had revenue of $245.30 million for the quarter, compared to the consensus estimate of $248.65 million. Endava had a return on equity of 2.75% and a net margin of 2.30%. On average, analysts expect Endava to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Endava Stock Performance
Shares of NYSE DAVA traded down $0.36 during trading hours on Tuesday, reaching $23.61. 300,960 shares of the stock were exchanged, compared to its average volume of 528,829. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.74 and a current ratio of 1.74. The firm has a market capitalization of $1.36 billion, a price-to-earnings ratio of 65.33 and a beta of 1.21. The stock's fifty day simple moving average is $27.42 and its 200 day simple moving average is $28.68. Endava has a 52 week low of $23.28 and a 52 week high of $81.06.
Analysts Set New Price Targets
Several equities analysts have weighed in on DAVA shares. JPMorgan Chase & Co. lifted their price objective on Endava from $41.00 to $47.00 and gave the company an "overweight" rating in a report on Friday, September 6th. Guggenheim dropped their target price on Endava from $55.00 to $45.00 and set a "buy" rating for the company in a research report on Monday, September 16th. Susquehanna reduced their price objective on shares of Endava from $66.00 to $55.00 and set a "positive" rating on the stock in a research note on Friday, September 20th. Citigroup lowered their price target on shares of Endava from $30.00 to $27.00 and set a "neutral" rating for the company in a report on Monday, October 28th. Finally, Needham & Company LLC cut their target price on Endava from $42.00 to $33.00 and set a "buy" rating on the stock in a research report on Friday, September 20th. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $41.71.
Get Our Latest Analysis on DAVA
Endava Company Profile
(
Get Free Report)
Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.
Read More
Before you consider Endava, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Endava wasn't on the list.
While Endava currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.